RxDoctor Payments Data

Molly White, MD

Family Medicine · Manassas, VANPI 1265699078

Payments from drug & device makers

$497in general payments, 2019–2025

Across 24 payments — averaging $20.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$142
  • Pfizer$85
  • Novo Nordisk$70
  • Lilly USA, LLC$53
  • Merck$48
  • Sanofi-aventis U.S. LLC$40
  • plus $60 from 3 others

What the payments were for

  • Food & beverage$497100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$497 in reported general payments places this provider in the 60th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$81,511
Medicare patients
228
Services billed
1,359

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide41$71,656
JardianceEmpagliflozin30$46,909
JanuviaSitagliptin Phosphate25$32,363
MounjaroTirzepatide12$15,640
EliquisApixaban11$15,505
Breo ElliptaFluticasone/Vilanterol13$11,359
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$4,960
Rosuvastatin Calcium242$3,472
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$3,148
Humalog Kwikpen U-100Insulin Lispro12$2,192
Atorvastatin Calcium259$2,058
Levothyroxine Sodium177$1,593
Gabapentin93$1,264
Albuterol Sulfate HfaAlbuterol Sulfate44$1,240
Methenamine Hippurate13$1,186

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$70$71,65641 claims
Boehringer IngelheimJardiance$21$46,90930 claims
MerckJanuvia$48$32,36325 claims
Lilly USA, LLCMounjaro$53$15,64012 claims
PfizerEliquis$85$15,50511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Manassas

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →